BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kostova V, Désos P, Starck JB, Kotschy A. The Chemistry Behind ADCs. Pharmaceuticals (Basel) 2021;14:442. [PMID: 34067144 DOI: 10.3390/ph14050442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Eras A, Castillo D, Suárez M, Vispo NS, Albericio F, Rodriguez H. Chemical Conjugation in Drug Delivery Systems. Front Chem 2022;10:889083. [DOI: 10.3389/fchem.2022.889083] [Reference Citation Analysis]
2 Gandullo-Sánchez L, Ocaña A, Pandiella A. Generation of Antibody-Drug Conjugate Resistant Models. Cancers (Basel) 2021;13:4631. [PMID: 34572858 DOI: 10.3390/cancers13184631] [Reference Citation Analysis]
3 Giese M, Davis PD, Woodman RH, Hermanson G, Pokora A, Vermillion M. Linker Architectures as Steric Auxiliaries for Altering Enzyme-Mediated Payload Release from Bioconjugates. Bioconjug Chem 2021;32:2257-67. [PMID: 34587447 DOI: 10.1021/acs.bioconjchem.1c00429] [Reference Citation Analysis]
4 Hammood M, Craig AW, Leyton JV. Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)-A Necessity for Future ADC Research and Development. Pharmaceuticals (Basel) 2021;14:674. [PMID: 34358100 DOI: 10.3390/ph14070674] [Reference Citation Analysis]
5 Salvati A, Poelstra K. Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation. Pharmaceutics 2022;14:217. [DOI: 10.3390/pharmaceutics14010217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cavaco M, Castanho MARB, Neves V. The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections. Front Microbiol 2022;13:835677. [PMID: 35330773 DOI: 10.3389/fmicb.2022.835677] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baldo S, Antunes P, Felicidade JF, Santos FMF, Arteaga JF, Fernandes F, Pischel U, Pinto SN, Gois PMP. The BASHY Platform Enables the Assembly of a Fluorescent Bortezomib-GV1001 Conjugate. ACS Med Chem Lett 2022;13:128-33. [PMID: 35059132 DOI: 10.1021/acsmedchemlett.1c00615] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sapozhnikova KA, Misyurin VA, Ryazantsev DY, Kokin EA, Finashutina YP, Alexeeva AV, Ivanov IA, Kocharovskaya MV, Tikhonova NA, Popova GP, Alferova VA, Ustinov AV, Korshun VA, Brylev VA. Sensitive Immunofluorescent Detection of the PRAME Antigen Using a Practical Antibody Conjugation Approach. Int J Mol Sci 2021;22:12845. [PMID: 34884647 DOI: 10.3390/ijms222312845] [Reference Citation Analysis]
9 Tong JTW, Harris PWR, Brimble MA, Kavianinia I. An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy. Molecules 2021;26:5847. [PMID: 34641391 DOI: 10.3390/molecules26195847] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]